[{"Assets_0_Q1_USD":276117000.0,"CommonStockSharesOutstanding_0_Q1_shares":32451000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-21119000.0,"NetIncomeLoss_1_Q1_USD":-13028000.0,"StockholdersEquity_0_Q1_USD":110286000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]